[O:1]=[S:2]1(=[O:23])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[C:14]([N:16]2[CH2:20][CH2:19][CH2:18][S:17]2(=[O:22])=[O:21])[CH:13]=[CH:12][C:8]=1[C:9](O)=[O:10].[CH3:24][C:25]1[C:26]([N:35]2[CH2:40][CH2:39][NH:38][CH2:37][CH2:36]2)=[N:27][CH:28]=[C:29]([C:31]([F:34])([F:33])[F:32])[CH:30]=1>>[O:23]=[S:2]1(=[O:1])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[C:14]([N:16]2[CH2:20][CH2:19][CH2:18][S:17]2(=[O:22])=[O:21])[CH:13]=[CH:12][C:8]=1[C:9]([N:38]1[CH2:39][CH2:40][N:35]([C:26]2[C:25]([CH3:24])=[CH:30][C:29]([C:31]([F:34])([F:32])[F:33])=[CH:28][N:27]=2)[CH2:36][CH2:37]1)=[O:10]Using 2,4-bis(1,1-dioxo-1λ6-isothiazolidin-2-yl)benzoic acid (200 mg) described in Preparation Example 34 and 1-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine (136 mg) described in Preparation Example 84 and by the reaction and treatment in the same manner as in Example 87, the title compound (172 mg) was obtained.